Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Feb. 04, 2023	Feb. 05, 2022
Cash flows from operating activities:
Net income	$ 3,056,967	$ 1,157,034
Adjustments to reconcile net income to net cash provide by operating activities:
Depreciation	39,279	43,227
Undistributed earnings in joint venture - Majestic 21	(22,826)	(12,557)
Decrease in fair market value of equity investments	17,942	4,093
Stock-based compensation	34,989	35,353
Amortization of operating lease right of use assets	0	1,597
Decrease (increase) in:
Accounts receivable - trade	(634,707)	186,724
Inventories	138,432	(193,311)
Prepaid expenses and other current assets	246,908	202,697
Interest receivable	(33,723)	0
(Decrease) increase in:
Accounts payable	(320,294)	58,905
Accrued compensation	(77,759)	37,776
Accrued expenses and other current liabilities	131,028	(88,108)
Income taxes payable	931,841	369,396
Customer deposits	(131,498)	(877,796)
Net cash provided by operating activities	3,376,579	925,030
Cash flows from investing activities:
Purchase of property, plant and equipment	(226,549)	(118,783)
Purchase certificates of deposit	(1,916,000)
Proceeds from certificates of deposit	0	2,087,936
Collections on interest receivable	0	5,079
Collections on mortgage notes receivable	188	627
Collections on equipment and other notes receivable	5,701	14,443
Issuance of mobile home park note receivable	0	(63,778)
Increase in cash surrender value of life insurance	(44,025)	(42,759)
Net cash (used in) provided by investing activities	(2,180,685)	1,882,765
Cash flows from financing activities:
Reduction of operating lease obligation	0	(1,597)
Net cash used in financing activities	0	(1,597)
Increase in cash and cash equivalents	1,195,894	2,806,198
Cash and cash equivalents at beginning of year	16,653,449	36,126,059
Cash and cash equivalents at end of quarter	17,849,343	38,932,257
Supplemental disclosure of cash flow information:
Noncash exercise of employee stock options	$ 0	$ (9,197)